Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
NCT01017796
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Contrast Induced Nephropathy
Interventions
DRUG:
N-acetylcysteine and ascorbic acid
Sponsor
University of Thessaly